Technical Analysis for RAPT - RAPT Therapeutics, Inc.

Grade Last Price % Change Price Change
F 18.15 -3.71% -0.70
RAPT closed down 3.71 percent on Friday, February 26, 2021, on 66 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RAPT trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -3.71%
Slingshot Bearish Bearish Swing Setup -8.56%
Multiple of Ten Bearish Other -8.56%
Hammer Candlestick Bullish -3.61%
Gapped Down Weakness -3.61%
Lower Bollinger Band Touch Weakness -3.61%
Multiple of Ten Bearish Other -5.81%
MACD Bearish Signal Line Cross Bearish -10.06%
Older End-of-Day Signals for RAPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 12 hours ago
Down 3% about 17 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
Fell Below Lower Bollinger Band about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

RAPT Therapeutics, Inc. Description

RAPT Therapeutics, Inc., a clinical stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company develops small molecules that are designed to modulate the critical immune responses underlying these diseases. Its lead oncology drug candidate is FLX475 for the treatment of a range of tumors; and RPT193, a CCR4 antagonist for allergic inflammatory disease. The company is also pursuing a range of targets, including general control nonderepressible and hematopoietic progenitor kinase for the treatment of cancer. RAPT Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Diseases Immunology Treatment Of Cancer Pharmacy Inflammatory Disease Inflammatory Diseases Tumors Specialty Drugs Immune Response Small Molecule Therapies Bristol Myers Squibb

Is RAPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.86
52 Week Low 10.52
Average Volume 180,802
200-Day Moving Average 25.23
50-Day Moving Average 20.86
20-Day Moving Average 20.37
10-Day Moving Average 19.85
Average True Range 1.12
ADX 19.71
+DI 13.73
-DI 30.19
Chandelier Exit (Long, 3 ATRs ) 18.77
Chandelier Exit (Short, 3 ATRs ) 21.38
Upper Bollinger Band 22.40
Lower Bollinger Band 18.35
Percent B (%b) -0.05
BandWidth 19.89
MACD Line -0.58
MACD Signal Line -0.34
MACD Histogram -0.2376
Fundamentals Value
Market Cap 445.68 Million
Num Shares 24.6 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -9.60
Price-to-Sales 111.36
Price-to-Book 4.27
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.33
Resistance 3 (R3) 20.52 20.00 19.96
Resistance 2 (R2) 20.00 19.44 19.90 19.84
Resistance 1 (R1) 19.07 19.10 18.81 18.88 19.72
Pivot Point 18.55 18.55 18.42 18.45 18.55
Support 1 (S1) 17.62 17.99 17.36 17.43 16.58
Support 2 (S2) 17.10 17.65 17.00 16.46
Support 3 (S3) 16.17 17.10 16.34
Support 4 (S4) 15.98